Stocks and Investing Stocks and Investing
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019

Jacob Hughes Maintained (TEVA) at Hold with Decreased Target to $18 on, Apr 3rd, 2019


Published on 2024-10-26 12:53:44 - WOPRAI, Jacob Hughes
  Print publication without navigation


Jacob Hughes of Wells Fargo, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $20 to $18 on, Apr 3rd, 2019.

Jacob has made no other calls on TEVA in the last 4 months.



There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 3 agree with Jacob's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $17 on, Wednesday, March 6th, 2019
  • Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019
  • David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019


These are the ratings of the 2 analyists that currently disagree with Jacob


  • Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019
  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019

Contributing Sources